Evidence map›Paper›PMID 37643009›Full record

ArticleThe Journal of clinical investigation2023

Epithelial TNF controls cell differentiation and CFTR activity to maintain intestinal mucin homeostasis.

Efren A Reyes, David Castillo-Azofeifa, Jérémie Rispal, Tomas Wald, Rachel K Zwick, Brisa Palikuqi, Angela Mujukian, Shervin Rabizadeh, Alexander R Gupta, James M Gardner and 3 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The function of chloride channels in digestive system disease (Review).International journal of molecular medicine · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Establishment of anMethodsX · 2024
    Article
  13. Challenges and opportunities in inflammatory bowel disease: from current therapeutic strategies to organoid-based models.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Efren A ReyesDepartment of Orofacial Sciences and Program in Craniofacial Biology, and.
David Castillo-AzofeifaDepartment of Orofacial Sciences and Program in Craniofacial Biology, and.
Jérémie RispalDepartment of Orofacial Sciences and Program in Craniofacial Biology, and.
Tomas WaldDepartment of Orofacial Sciences and Program in Craniofacial Biology, and.
Rachel K ZwickDepartment of Orofacial Sciences and Program in Craniofacial Biology, and.
Brisa PalikuqiDepartment of Orofacial Sciences and Program in Craniofacial Biology, and.
Angela MujukianF. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Shervin RabizadehF. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Alexander R GuptaDepartment of Surgery, and.
James M GardnerDepartment of Surgery, and.
Dario BoffelliDepartment of Pediatrics, Cedars-Sinai Guerin Children's, Los Angeles, California, USA.
Zev J GartnerDepartment of Pharmaceutical Chemistry and TETRAD Program, UCSF, San Francisco, California, USA.
Ophir D KleinDepartment of Orofacial Sciences and Program in Craniofacial Biology, and.
University of California, San Francisco · USCedars-Sinai Medical Center · USCalifornia Institute for Regenerative Medicine · US

Funding

UCSF Nutrition Obesity Research CenterP30DK098722 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHRISTIAN VAISSE · 2015 to 2026
$14.6M
Maximizing Opportunities for Research Excellence - Evaluation Training SupplementR25GM056847 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DUNCAN, D'ANNE S., SELLO, JASON K · 1998 to 2023
$14.1M
The roles of regional specialization, mechanical forces and epigenetic memory after perturbation and injury of the intestinal stem cell microenvironmentU01DK103147 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KLEIN, OPHIR D · 2014 to 2023
$5.4M
The physical and molecular mechanisms of intestinal villus morphogenesis and repairR01DK126376 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Zev Jordan Gartner · 2020 to 2026
$4.2M
Filling a Void of Research (FAVOR) Training for Transplant SurgeonsT32AI125222 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PETER G STOCK, Minnie M Sarwal · 2016 to 2026
$3.4M
The roles of cell death and mechanical signaling in aging intestinal stem cellsK99AG071933 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CASTILLO-AZOFEIFA, DAVID · 2022 to 2022
$125k
NIAID NIH HHS T32 AI125222NIA NIH HHS K99 AG071933NIDDK NIH HHS P30 DK098722NIDDK NIH HHS R01 DK126376NIDDK NIH HHS U01 DK103147NIGMS NIH HHS R25 GM056847
6 · The paper itself

Abstract

The gastrointestinal tract relies on the production, maturation, and transit of mucin to protect against pathogens and to lubricate the epithelial lining. Although the molecular and cellular mechanisms that regulate mucin production and movement are beginning to be understood, the upstream epithelial signals that contribute to mucin regulation remain unclear. Here, we report that the inflammatory cytokine tumor necrosis factor (TNF), generated by the epithelium, contributes to mucin homeostasis by regulating both cell differentiation and cystic fibrosis transmembrane conductance regulator (CFTR) activity. We used genetic mouse models and noninflamed samples from patients with inflammatory bowel disease (IBD) undergoing anti-TNF therapy to assess the effect of in vivo perturbation of TNF. We found that inhibition of epithelial TNF promotes the differentiation of secretory progenitor cells into mucus-producing goblet cells. Furthermore, TNF treatment and CFTR inhibition in intestinal organoids demonstrated that TNF promotes ion transport and luminal flow via CFTR. The absence of TNF led to slower gut transit times, which we propose results from increased mucus accumulation coupled with decreased luminal fluid pumping. These findings point to a TNF/CFTR signaling axis in the adult intestine and identify epithelial cell-derived TNF as an upstream regulator of mucin homeostasis.

Indexed as

Cystic Fibrosis Transmembrane Conductance RegulatorMucinsAnimalsCell DifferentiationEpithelial CellsHomeostasisHumansMiceTumor Necrosis Factor InhibitorsTumor Necrosis FactorsCFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorMucinsTumor Necrosis Factor InhibitorsTumor Necrosis FactorsCytokinesEpithelial transport of ions and waterGastroenterologyMolecular genetics

Identifiers

PMID37643009
PMCPMC10575728
OpenAlexW4386250274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.